New laser could ease glaucoma for chinese patients
NCT ID NCT05902871
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 32 times
Summary
This study tests a new laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) in 45 Chinese patients with glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure over 6 to 12 months. Participants must have mild to moderate disease and good vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
C-Mer Eye Clinic
COMPLETEDHong Kong, China
-
SERI
RECRUITINGSingapore, Singapore
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.